Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
2,589
Views
1
CrossRef citations to date
0
Altmetric
Allergy

The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients

M. Müllera Unit of Health Economics, WifOR Institute, Darmstadt, Hesse, GermanyCorrespondence[email protected]
,
A. Igarashib Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama, Japan;c Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, JapanORCID Iconhttps://orcid.org/0000-0001-6307-6916
ORCID Icon,
K. Hashiguchid Unit of Otorhinolaryngology, Futaba Clinic, Tokyo, Japan
,
M. Kappela Unit of Health Economics, WifOR Institute, Darmstadt, Hesse, Germany
,
F. Paolinia Unit of Health Economics, WifOR Institute, Darmstadt, Hesse, GermanyORCID Iconhttps://orcid.org/0000-0001-8789-3670
ORCID Icon,
H. Yoshisuee Unit of Health Economics, Novartis Pharma K.K, Tokyo, Japan
,
M. Funakuboe Unit of Health Economics, Novartis Pharma K.K, Tokyo, Japan
,
H. Sharmaf Novartis Corporation Sdn. Bhd, Selangor, Malaysia
&
M. Okanog School of Medicine, International University of Health and Welfare, Narita, Japan
 show all
Pages 220-229 | Received 13 Dec 2021, Accepted 20 Jan 2022, Published online: 09 Feb 2022

Related Research Data

The impact of omalizumab on paid and unpaid work productivity among severe Japanese cedar pollinosis (JCP) patients
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.